CORAL SPRINGS, Florida, November 11, 2015 /PRNewswire/ --
Fueled by the continued rise of nutritional protein & nutraceutical supplements as essential nutrients to achieve an improved lifestyle & healthy overall condition, pharmaceutical & nutritional supplements are attracting more and more consumers looking to maintain a healthy and active way of life in their busy schedule. Nutritional and Pharmaceutical Companies with recent developments of note to keep tabs on are Axxess Pharma Inc. (OTC: AXXE), USANA Health Sciences Inc. (NYSE: USNA), The Vitamin Shoppe Inc. (NYSE: VSI), GNC Holdings, Inc. (NYSE: GNC) & Mylan N.V. (NASDAQ: MYL)
Axxess Pharma Inc. (OTC: AXXE) a specialty pharmaceutical and nutritional supplements company, is pleased to announce that Midwest Logistics has issued a purchase order for Axxess Pharma's entire line of all-natural Tapout nutritional supplements and pain relief sprays. Midwest Logistics is a rapidly growing, worldwide wholesale distributor of health, fitness and supplement products. Currently, Midwest Logistics will be selling their initial Tapout products on fifteen online, high traffic sports and nutrition retail sites including, https://www.basupps.com/ProductSearch/All/All/0/Tapout/1/0/. In addition to the high traffic retail sites, Midwest has a large team of inside representatives selling products to over 400 companies.
Read the full AXXE press release at http://www.financialnewsmedia.com/profiles/axxe.html
Dr. Bagi, President of Axxess Pharma stated, "We are honored to receive Midwest Logistic's, first large purchase order of our all natural supplements and pain relief sprays. There is a strong synergy between our product lines and their large, devoted, health and wellness customer base. We anticipate purchase orders to increase on a monthly basis and include all of our products lines." Dr. Bagi further stated, "This is yet another sign of our continued product expansion and increasing demand from global distributors."
In recent nutritional supplement news: USANA Health Sciences (NYSE: USNA) News - Containing 12 billion colony-forming bacteria per serving, USANA® Probiotic receives the renowned seal of approval from ConsumerLab.com, an independent testing body of health and nutrition products. This reputable seal distinguishes USANA as a high-quality supplement manufacturer, ensuring what is on the label is indeed in the product. "Each time we receive a seal of approval from ConsumerLab.com, we know the high manufacturing standards we set for ourselves make a huge difference in the quality of our products," says Dan Macuga, USANA's chief communications officer. To achieve a passable score by ConsumerLab.com, rigorous tests are conducted to ensure label accuracy. For USANA® Probiotic, a minimum of 100% of its labeled amount of microorganisms per daily serving were required to pass, with no contamination mold or other pathogenic organisms. USANA Probiotic was also found to meet its "gluten-free" claim.
The Vitamin Shoppe (NYSE: VSI) last month announced the launch of an exciting, new product category - Protein Pantry. Over the past few months, the Vitamin Shoppe has introduced new, protein-packed foods such as pancake mixes, nut butters and spreads, powdered peanut butter and more. The Vitamin Shoppe now boasts a unique, specially curated assortment of protein-infused foods. The new Protein Pantry assortment is now available at approximately 700 Vitamin Shoppe locations across the country and online at VitaminShoppe.com.
GNC Holdings, Inc. (NYSE: GNC), a leading global specialty health, wellness and performance retailer, reported yesterday that Mike Archbold, CEO and Tricia Tolivar, Executive Vice President & CFO will be presenting at Morgan Stanley's Global Consumer & Retail Conference on November 17, 2015 at the Crowne Plaza Times Square. The presentation, which is scheduled for 10:00 am EST, will be available via webcast on the Investor Relations section of the Company's website.
In other pharmaceutical developments of importance this week: Perrigo Company plc (NYSE: PRGO) issued the following response to Mylan's press release yesterday. Mylan (NASDAQ: MYL) is resorting to desperate tactics on the eve of its tender offer deadline, having failed to persuade our long-term shareholders of the merits of its inadequate offer.
First, as much as Mylan would like to highlight made-up numbers, the actual premium it has offered is one of the lowest on record. It is simply not an acceptable change of control premium, and the grossly inadequate offer does not even remotely reflect the value of the terrific growth company Perrigo shareholders own; Perrigo has outperformed Mylan significantly and has returned a Total Shareholder Return of 971% since 2007.i Over the past three years, Perrigo shares have traded at an average P/E multiple of 20.2x while Mylan has underperformed its peers at an average P/E multiple of 10.6x,ii highlighting the fundamental difference in performance and growth prospects between our companies. Applying Perrigo's proven multiple to its 2016 expected earnings of $9.45iii (including share repurchase) shows the tremendous value, in excess of Mylan's offer, that lies ahead for Perrigo shares. Read the full story at http://finance.yahoo.com/news/perrigo-reaffirms-views-mylans-inadequate-145400830.html
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at financialnewsmedia.com. Follow us on Facebook: facebook.com/financialnewsmedia and Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated two thousand five hundred dollars for news coverage of the current press release issued by Axxess Pharma Inc. by the company. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
SOURCE FN Media Group, LLC